Hypoxia, HIF1 and glucose metabolism in the solid tumour
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
It has been known for many years that cellular metabolism within the solid tumour is markedly different from that of the corresponding normal tissue. The transcription factor hypoxia-inducible factor 1 (HIF1) has been implicated in regulating many of the genes that are responsible for the metabolic difference. However, it remains unclear how this 'aerobic glycolysis', originally described by Otto Warburg, offers tumour cells a growth advantage. As discussed in this Perspective, new data suggests that this metabolic switch may provide a benefit to the tumour not by increasing glycolysis but by decreasing mitochondrial activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated HIF-1 plays a crucial role in adaptive responses of the tumor cells to changes in oxygen through transcriptional activation of over 100 downstream genes which regulate vital biological processes required for tumor survival and progression.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1 mediates this metabolic conversion through the induction of enzymes involved in the glycolysis pathway and overexpression of glucose transporters (GLUTs) which increase glucose import into tumor cells3.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1α is activated due to blockade of its degradation pathway mediated by low oxygen levels, thereby increasing the expression of target genes, including those encoding glycolytic enzymes and glucose transporters, and increasing lactate secretion67.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [67]
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“Tumour cells respond to these conditions, and adapt their metabolism to adjust the O 2 demand to meet the limited suppl”
Background
Cited by
Items 701–800 of 1,002
MYC Degradation under Low O2 Tension Promotes Survival by Evading Hypoxia-Induced Cell Death
Wong, W. J., Qiu, B., Nakazawa, M. S., Qing, G., & Simon, M. C. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00853-12 · Cited by 43
Liang, Y. J., Li, W., Yang, B., Tao, Z., Sun, H., Wang, L., Xia, J., Qin, L., Tang, Z., Fan, J., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26166 · Cited by 43
CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells
Lehnus, K. S., Donovan, L., Huang, X., Zhao, N., Warr, T. J., Pilkington, G. J., & An, Q. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1787 · Cited by 44
Chien, W., Lee, K. L., Ding, L., Wuensche, P., Kato, H., Doan, N., Poellinger, L., Said, J. W., & Koeffler, H. P. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.531 · Cited by 43
Storm, P., Aits, S., Puthia, M., Urbano, A., Northen, T. R., Powers, S., Bowen, B. P., Chao, Y., Reindl, W., Lee, D. Y., et al. (2011) · Oncogene · doi:10.1038/onc.2011.196 · Cited by 43
Sanders, E. B., & Diehl, S. (2015) · Oncoscience · doi:10.18632/oncoscience.128 · Cited by 46
Campbell, K., Herrera-Domínguez, L., Correia‐Melo, C., Zelezniak, A., & Ralser, M. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.12.001 · Cited by 45
Lee, H.-C., Lin, S.-C., Wu, M.-H., & Tsai, S.-J. (2019) · Reproductive Sciences · doi:10.1177/1933719118789513 · Cited by 38
Current Understanding of the HIF-1-Dependent Metabolism in Oral Squamous Cell Carcinoma
Eckert, A. W., Kappler, M., Große, I., Wickenhauser, C., & Seliger, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176083 · Cited by 43
CA IX Stabilizes Intracellular pH to Maintain Metabolic Reprogramming and Proliferation in Hypoxia
Benej, M., Švastová, E., Banova, R., Kopáček, J., Gibadulinová, A., Kery, M., Arena, S., Scaloni, A., Vitale, M., Zambrano, N., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01462 · Cited by 46
Self-citationRuiz, N. P. E., Mohan, V., Wu, J., Scott, S. A., Kreamer, M., Benej, M., Golias, T., Papandreou, I., & Denko, N. C. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00275-4 · Cited by 46
Self-citationDai, Q., Yin, Y., Liu, W., Wei, L., Zhou, Y., Li, Z., You, Q., Lu, N., & Guo, Q. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.04.015 · Cited by 43
Metabolic reprogramming in Rheumatoid Arthritis Synovial Fibroblasts: A hybrid modeling approach
Aghakhani, S., Soliman, S., & Niarakis, A. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010408 · Cited by 46
Rising Influence of Nanotechnology in Addressing Oxidative Stress-Related Liver Disorders
Padmanaban, S., Pully, D., Samrot, A. V., Gosu, V., Sadasivam, N., Park, I., Radhakrishnan, K., & Kim, D. (2023) · Antioxidants · doi:10.3390/antiox12071405 · Cited by 51
Wan, X., Xie, M., Xu, H., Wei, Z., Yao, H., Wang, Z., & Zheng, D. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02052-4 · Cited by 43
Zhou, R., Zeng, X., Zhao, H., Chen, Q., & Wu, P. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214306 · Cited by 45
Peng, K., Zhuo, M., Li, M., Chen, Q., Mo, P., & Yu, C. (2020) · Oncogene · doi:10.1038/s41388-020-01483-w · Cited by 44
Jin, Y., Bian, S., Wang, H., Mo, J., He, F., Li, L., Chen, T., & Jiang, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05129-5 · Cited by 45
Zia, S., Hammond, B. P., Zirngibl, M., Sizov, A., Baaklini, C. S., Panda, S. P., Ho, M. F. S., Lee, K. V., Mainali, A., Burr, M. K., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00584-2 · Cited by 40
“Hif1a acts as a metabolic regulator known to enhance glycolysis and upregulate glucose transporters [81].”
BackgroundOxygen metabolism in oral cancer: HIF and GLUTs (Review)
Pereira, K. M. A., Chaves, F. N., VIANA, T. S. A., Carvalho, F. S. R., Costa, F. W. G., Alves, A. P. N. N., & Sousa, F. B. (2013) · Oncology Letters · doi:10.3892/ol.2013.1371 · Cited by 44
Characterization and Analysis of Human Chordoma Cell Lines
Cao, Y., Hornicek, F. J., Wood, K. B., Schwab, J. H., Choy, E., Iafrate, J., Rosenberg, A. E., Nielsen, G. P., Xavier, R. J., Mankin, H. J., et al. (2010) · Spine · doi:10.1097/brs.0b013e3181c2a8b0 · Cited by 40
Hwang, S., Kim, H., Min, M. S., Raghunathan, R., Panova, I. P., Munshi, R., & Ryu, B. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.160 · Cited by 43
p38α Is Required for Ovarian Cancer Cell Metabolism and Survival
Matrone, A., Grossi, V., Chiacchiera, F., Fina, E., Cappellari, M., Caringella, A. M., Naro, E. D., Loverro, G., & Simone, C. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181c8ca12 · Cited by 40
Eskandani, M., Vandghanooni, S., Barar, J., Nazemiyeh, H., & Omidi, Y. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.113 · Cited by 44
Pelaz, S. G., Jaraíz-Rodríguez, M., Álvarez-Vázquez, A., Talaverón, R., García-Vicente, L., Flores-Hernández, R., de Cedrón, M. G., Tabernero, M., de Molina, A. R., Lillo, C., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103134 · Cited by 43
Giafaglione, J. M., Crowell, P. D., Delcourt, A. M. L., Hashimoto, T., Ha, S. M., Atmakuri, A., Nunley, N. M., Dang, R. M. A., Tian, M., Diaz, J. A., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01274-x · Cited by 45
Luo, H., Wang, Q., Yang, F., Liu, R. R., Gao, Q., Cheng, B., Lin, X., Huang, L., Chen, C., Jin, X., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.164968 · Cited by 220
Pattern-Recognition Receptors and Immunometabolic Reprogramming: What We Know and What to Explore
Kumar, V., & Stewart, J. H. (2024) · Journal of Innate Immunity · doi:10.1159/000539278 · Cited by 45
Structural and functional consequences of succinate dehydrogenase subunit B mutations
Kim, E., Rath, E. M., Tsang, V., Duff, A. P., Robinson, B. G., Church, W. B., Benn, D. E., Dwight, T., & Clifton-Bligh, R. J. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0099 · Cited by 39
ARNT2 Regulates Tumoral Growth in Oral Squamous Cell Carcinoma
Kimura, Y., Kasamatsu, A., Nakashima, D., Yamatoji, M., Minakawa, Y., Koike, K., Fushimi, K., Higo, M., Endo‐Sakamoto, Y., Shiiba, M., et al. (2016) · Journal of Cancer · doi:10.7150/jca.14208 · Cited by 43
Kouidhi, S., Noman, M. Z., Kieda, C., Elgaaied, A. B., & Chouaib, S. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00114 · Cited by 36
New insight into the role of metabolic reprogramming in melanoma cells harboring BRAF mutations
Ferretta, A., Maida, I., Guida, S., Azzariti, A., Porcelli, L., Tommasi, S., Zanna, P. T., Cocco, T., Guida, M., & Guida, G. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.08.007 · Cited by 45
Fei, M., Guan, J., Xue, T., Qin, L., Tang, C., Cui, G., Wang, Y., Gong, H., & Feng, W. (2018) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-018-0100-6 · Cited by 40
Lu, J., Chen, H., He, F., You, Y., Feng, Z., Chen, W., Xu, L., & Zhao, L. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13321 · Cited by 39
Metabolic Implications of Immune Checkpoint Proteins in Cancer
Stirling, E. R., Bronson, S. M., Mackert, J. D., Cook, K. L., Triozzi, P. L., & Soto‐Pantoja, D. R. (2022) · Cells · doi:10.3390/cells11010179 · Cited by 41
Sládek, M., Polidarová, L., Nováková, M., Parkanová, D., & Sumová, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046951 · Cited by 40
Central and peripheral nervous systems: master controllers in cancer metastasis
Shi, M., Liu, D., Yang, Z., & Guo, N. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9440-x · Cited by 43
Role of glycogen synthase kinase following myocardial infarction and ischemia–reperfusion
Ghaderi, S., Alidadiani, N., Dilaver, N., Heidari, H. R., Parvizi, R., Rahbarghazi, R., Soleimanirad, J., & Baradaran, B. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1376-0 · Cited by 39
Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells
Gebregiworgis, T., Purohit, V., Shukla, S. K., Tadros, S., Chaika, N. V., Abrego, J., Mulder, S. E., Gunda, V., Singh, P. K., & Powers, R. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00246 · Cited by 40
Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy
Allam, A. H., Yakou, M. H., Pang, L., Ernst, M., & Huynh, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767939 · Cited by 42
Custom‐Made Piezoelectric Solid Solution Material for Cancer Therapy
Lv, S., Qiu, Z., Yu, D., Wu, X., Yan, X., Ren, Y., Huang, Y., Jiang, G., & Gao, F. (2023) · Small · doi:10.1002/smll.202300976 · Cited by 38
Recent advances in glucose oxidase-based nanocarriers for tumor targeting therapy
Su, L., Wang, Q., Jia, Z., Da, M., Zhao, J., Yang, R., & Chen, D. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20407 · Cited by 52
Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming
Han, X., Zhu, Y., Ke, J., Zhai, Y., Huang, M., Zhang, X., He, H., Zhang, X., Zhao, X., Guo, K., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02092-2 · Cited by 44
Overview of mechanisms and novel therapies on rheumatoid arthritis from a cellular perspective
Han, P., Liu, X., He, J., Luyang, H., & Li, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1461756 · Cited by 42
Momose, I., Ohba, S., Tatsuda, D., Kawada, M., Masuda, T., Tsujiuchi, G., Yamori, T., Esumi, H., & Ikeda, D. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.050 · Cited by 39
Elevated citrate in pediatric astrocytomas with malignant progression
Blüml, S., Panigrahy, A., Laskov, M., Dhall, G., Krieger, M. D., Nelson, M., Finlay, J. L., & Gilles, F. H. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor087 · Cited by 40
Normoxic accumulation of HIF1α is associated with glutaminolysis
Kappler, M., Pabst, U., Rot, S., Taubert, H. W., Wichmann, H., Schubert, J., Bache, M., Weinholdt, C., Immel, U., Große, I., et al. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-016-1780-9 · Cited by 39
HIF-1α promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model
Zhu, J., Huang, Z., Zhang, M., Wang, W., Liang, H., Zeng, J., Wu, K., Wang, X., Hsieh, J., Guo, P., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.7764 · Cited by 43
Macropinocytosis and autophagy crosstalk in nutrient scavenging
Florey, O., & Overholtzer, M. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0154 · Cited by 41
Li, H., Zhang, X., Lin, X., Zhuang, S., Wu, Y., Liu, Z., Rong, J., & Zhao, J. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02684c · Cited by 40
Aboulthana, W. M., Ibrahim, N. E., Osman, N. M., Seif, M., Hassan, A. K., Youssef, A. M., El-Feky, A. M., & Madboli, A. E.-N. A. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.5.1369 · Cited by 38
Wang, X., Xiong, T., Cui, M., Guan, X., Yuan, J., Wang, Z., Li, R., Zhang, H., Duan, S., & Wei, F. (2020) · Applied Materials Today · doi:10.1016/j.apmt.2020.100827 · Cited by 40
SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma
Zhan, Y.-T., Li, L., Zeng, T., Zhou, N., Guan, X., & Li, Y. (2020) · Aging · doi:10.18632/aging.202164 · Cited by 43
Zheng, N., Luo, X., Zhang, Z., Wang, A., & Song, W. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c07662 · Cited by 38
Li, L., Feng, C., Qin, J., Li, D., Liu, M., Han, S., & Zheng, B. Q. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104409 · Cited by 39
Ooi, A., & Furge, K. A. (2012) · 癌症:英文版 · doi:10.5732/cjc.012.10102 · Cited by 41
The real face of HIF1α in the tumor process
Kappler, M., Taubert, H. W., Schubert, J., Vordermark, D., & Eckert, A. W. (2012) · Cell Cycle · doi:10.4161/cc.21854 · Cited by 39
Utility of the succinate:fumarate ratio for assessing SDH dysfunction in different tumor types
Kim, E., Wright, M. J., Sioson, L., Novos, T., Gill, A. J., Benn, D. E., White, C., Dwight, T., & Clifton-Bligh, R. J. (2016) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2016.12.006 · Cited by 41
Non-invasive biomarkers for monitoring the immunotherapeutic response to cancer
Nisar, S., Bhat, A. A., Hashem, S., Yadav, S. K., Rizwan, A., Singh, M. K., Bagga, P., Macha, M. A., Frenneaux, M. P., Reddy, R. D., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02656-7 · Cited by 38
Yu, M., & Li, Z. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0546-3 · Cited by 39
Life History Trade-Offs in Tumors
Boddy, A. M., Huang, W., & Aktipis, A. (2018) · Current Pathobiology Reports · doi:10.1007/s40139-018-0188-4 · Cited by 38
Role of multifaceted regulators in cancer glucose metabolism and their clinical significance
Zhao, L., Mao, Y., Zhao, Y., Cao, Y., & Chen, X. (2016) · Oncotarget · doi:10.18632/oncotarget.7765 · Cited by 40
Jiang, X., Baucom, C. C., & Elliott, R. L. (2019) · Antibiotics · doi:10.3390/antibiotics8030110 · Cited by 44
Zhang, K., Xu, P., Sowers, J. L., Machuca, D. F., Mirfattah, B., Herring, J. L., Tang, H. R., Chen, Y., Tian, B., Brasier, A. R., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000154 · Cited by 39
Ma, L., Zhang, B., Zhou, C., Li, Y., Li, B., Yu, M., Luo, Y., Gao, L., Zhang, D., Xue, Q., et al. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.09.034 · Cited by 38
Feng, B., Zhu, Y., Sun, C., Su, Z., Tang, L., Li, C., & Zheng, G. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.06.189 · Cited by 38
Inhibition of the HIF‐1α/BNIP3 pathway has a retinal neuroprotective effect
Kunimi, H., Lee, D., Ibuki, M., Katada, Y., Negishi, K., Tsubota, K., & Kurihara, T. (2021) · The FASEB Journal · doi:10.1096/fj.202100572r · Cited by 37
Ishida, T., Takahashi, T., Kurokawa, Y., Nishida, T., Hirota, S., Serada, S., Fujimoto, M., Naka, T., Teranishi, R., Saito, T., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01566-9 · Cited by 38
Current Status and Future Directions of Bacteria-Based Immunotherapy
Tang, Q., Peng, X., Xu, B., Zhou, X., Chen, J., & Cheng, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.911783 · Cited by 41
Energy sources identify metabolic phenotypes in pancreatic cancer
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw097 · Cited by 42
The TGF-β/HDAC7 axis suppresses TCA cycle metabolism in renal cancer
Nam, H., Kundu, A., Karki, S., Brinkley, G. J., Chandrashekar, D. S., Kirkman, R. L., Liu, J., Liberti, M. V., Locasale, J. W., Mitchell, T., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.148438 · Cited by 36
“Glycolytic enzymes are known HIF transcriptional targets in cancer (6, 7).”
BackgroundGong, L., Liang, J., Xie, L., Zhang, Z., Mei, Z., & Zhang, W. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240131121032 · Cited by 37
Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer
Eberly, H. W., Sciscent, B. Y., Lorenz, F. J., Rettig, E. M., & Goyal, N. (2024) · Biomedicines · doi:10.3390/biomedicines12020415 · Cited by 39
Enhanced Cuproptosis via Metabolic Reprogramming Using Copper-Delivering Co–N–C Single-Atom Nanozyme
Kim, K., Lee, J., Park, O. K., Lee, H., Jang, T., Kim, J., Lee, B., Kim, J. H., Moon, J., Back, S., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c00012 · Cited by 37
Sawayama, H., Ishimoto, T., Watanabe, M., Yoshida, N., Baba, Y., Sugihara, H., Izumi, D., Kurashige, J., & Baba, H. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3371-1 · Cited by 39
Loja, M. N., Luo, Z., Farwell, D. G., Luu, Q. C., Donald, P. J., Amott, D., Truong, A. Q., Gandour‐Edwards, R. F., & Nitin, N. (2012) · International Journal of Cancer · doi:10.1002/ijc.27837 · Cited by 39
Hypoxia alters testicular functions of marine medaka through microRNAs regulation
Tse, A. C.-K., Li, J., Wang, S. Y., Chan, T., Lai, K. P., & Wu, R. S. S. (2016) · Aquatic Toxicology · doi:10.1016/j.aquatox.2016.10.007 · Cited by 37
MiR-182 promotes glucose metabolism by upregulating hypoxia-inducible factor 1α in NSCLC cells
Wang, M., Wang, W., Wang, J., & Zhang, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.035 · Cited by 36
Metabolic Strategies for Inhibiting Cancer Development
Icard, P., Loi, M., Wu, Z., Ginguay, A., Lincet, H., Robin, E., Coquerel, A., Berzan, D., Fournel, L., & Alifano, M. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa174 · Cited by 41
The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma
Paradžik, T., Bandini, C., Mereu, E., Labrador, M., Taìana, E., Amodio, N., Neri, A., & Piva, R. (2021) · Cancers · doi:10.3390/cancers13061235 · Cited by 39
Gramantieri, L., Giovannini, C., Piscaglia, F., & Fornari, F. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s268292 · Cited by 37
Cheng, W., Cheng, Z., Weng, L., Xing, D., & Zhang, M. (2021) · Journal of Cancer · doi:10.7150/jca.51407 · Cited by 36
Liu, Y., Ji, X., Tong, W. W. L., Askhatova, D., Yang, T., Cheng, H., Wang, Y. Z., & Shi, J. (2017) · Angewandte Chemie · doi:10.1002/ange.201710144 · Cited by 37
Scatena, R., Bottoni, P., Pontoglio, A., & Giardina, B. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900157 · Cited by 40
Liu, X., Chen, Q., Yang, G., Zhang, L., Liu, Z., Cheng, Z., & Zhu, X. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00070j · Cited by 36
Uncovering the role of hypoxia inducible factor-1α in skin carcinogenesis
Nys, K., Maes, H., Dudek, A. M., & Agostinis, P. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.02.001 · Cited by 40
Chikamoto, A., Inoue, R., Komohara, Y., Sakamaki, K., Hashimoto, D., Shiraishi, S., Takamori, H., Yamashita, Y., Yoshida, N., Yamanaka, T., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-5799-1 · Cited by 37
Metabolic Reprogramming: A Friend or Foe to Cancer Therapy?
McCann, C. K., & Kerr, E. M. (2021) · Cancers · doi:10.3390/cancers13133351 · Cited by 37
Liu, X., Deng, H., Tang, J., Wang, Z., Zhu, C., Cai, X., Rong, F., Chen, X., Sun, X., Jia, S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05008-z · Cited by 38
Nakaoka, H. J., Hara, T., Yoshino, S., Kanamori, A., Matsui, Y., Shimamura, T., Sato, H., Murakami, Y., Seiki, M., & Sakamoto, T. (2016) · Scientific Reports · doi:10.1038/srep22784 · Cited by 35
Zhang, B., Wu, J., Cai, Y., Luo, M., Wang, B., & Gu, Y. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz015 · Cited by 33
Cai, F., Liu, S., Lei, Y., Jin, S., Guo, Z., Zhu, D., Guo, X., Zhao, H.-Q., Niu, X., Xi, Y., et al. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104421 · Cited by 35
Advanced nanomedicines for the regulation of cancer metabolism
Yang, J., Zhao, Y., Zhou, Y., Wei, X., Wang, H., Si, N., Yang, J. H., Zhao, Q., Bian, B., & Zhao, H. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121565 · Cited by 38
The APE1/REF-1 and the hallmarks of cancer
Siqueira, P. B., Rodrigues, M. M. D. S., de Amorim, Í. S. S., Farias, T. G., Oliveira, M. D. S., Rodrigues, J. A., da Fonseca, A. D. S., & Mencalha, A. L. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-08946-9 · Cited by 37
Demasi, A. P. D., Costa, A. F., Altemani, A., Furuse, C., de Araújo, N. S., & de Araújo, V. C. (2010) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00702.x · Cited by 35
Xu, Y., Lu, J., Tang, Y., Xie, W., Zhang, H., Wang, B., Zhang, S., Hou, W., Zou, C., Jiang, P., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.12.032 · Cited by 34
RetractedMitchener, M. M., Begley, T. J., & Dedon, P. C. (2023) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00572 · Cited by 36
Altered glucose metabolism in Harvey-rastransformed MCF10A cells
Zheng, W., Tayyari, F., Gowda, G. A. N., Raftery, D., McLamore, E. S., Porterfield, D. M., Donkin, S. S., Bequette, B. J., & Teegarden, D. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22079 · Cited by 39
Cairns, R. A., Bennewith, K. L., Graves, E. E., Giaccia, A. J., Chang, D. T., & Denko, N. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1676 · Cited by 35
Self-citationKawaguchi, M., Aoki, S., Hirao, T., Morita, M., & Ito, K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.098 · Cited by 34
Metadata
- Authors
- Denko, N. C.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Denko, Nicholas C.
- ORCID
- Denko, Nicholas C.
- Venue
- Nature Reviews Cancer
- Published
- 2008-08-14
- Volume
- 8
- Issue
- 9
- Pages
- 705-713
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2066379425
- Cited by
- 1,707
- References
- 126
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 93 · 2023: 113 · 2022: 141 · 2021: 149 · 2020: 115 · 2019: 120 · 2018: 126 · 2017: 94 · 2016: 115 · 2015: 78 · 2014: 95 · 2013: 79 · 2012: 77
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P01CA067166)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- hypoxia, HIF-1, glucose metabolism, solid tumors, aerobic glycolysis, Warburg effect, cancer metabolism, mitochondrial activity, tumor growth
- MeSH terms
- Cell Division, Glucose, Glycolysis, Humans, Mitochondria, Models, Biological, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.